The treatment of unresectable liver cancer has long been a challenge in the medical field. However, a recent randomized trial called EMERALD-1 has shown promising results in improving outcomes using transarterial chemoembolization (TACE) in combination with immunotherapy. This article will analyze the trial and its implications for the treatment of hepatocellular carcinoma (HCC). The EMERALD-1
In a sheer twist of fate, Sean Strickland and Dricus Du Plessis, who were involved in an unexpected brawl just weeks ago, are now slated to face off in the highly anticipated main event of UFC 297. Set to take place this Saturday at the prestigious Scotiabank Arena in Toronto, this middleweight showdown promises to